The effects of apixaban were similar among patients with and without prior CAD on reducing stroke or systemic embolism and death from any cause ( hazard ratio [ HR ] 0.95 , 95 % confidence interval [ CI ] 0.71-1 .27 , P for interaction = 0.12 ; HR 0.96 , 95 % CI 0.81-1 .13 , P for interaction = 0.28 ) .
